Assessing the Risk of Neonatal Opioid Toxicity from Breastfeeding: Challenge to the Pediatric Clinical Pharmacology Modeling and Simulation Community
Clinical Pharmacology & Therapeutics · 16.11.2026
DOI: 10.1002/cpt.70554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 16.11.2026. Verfasst von J. Steven Leeder und 4 weiteren Autor:innen. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Hebammenwesen und Geburtshilfe, Stillen, Simulation in der Pflegeausbildung
Abstract (Originalsprache)
The safety of maternal codeine use during breastfeeding remains controversial, largely due to debate surrounding the “Toronto Case,” in which a neonatal death was associated with elevated morphine exposure following maternal postpartum codeine therapy. Critics have argued that this outcome requires an exceptionally unlikely combination of several factors. This review details the physiological and pharmacokinetic complexities of infant opioid exposure and toxicity in breastfed infants by reexamining assumptions underlying the physiology‐based pharmacokinetic (PBPK) model frequently cited to challenge the plausibility of the Toronto Case. When advances in developmental pharmacology, pharmacogenomics, and maternal and neonatal drug disposition that have occurred over the past 15 years are considered, an integrated mother‐milk–infant system emerges in which individualized risk assessment can be conceptualized as the convergence of multiple factors, each of which contributes to the overall risk for a given mother–child dyad. Future modeling and simulations must include the maternal and neonatal determinants that predispose specific breastfeeding mother–newborn pairs to excessive sedation and respiratory failure after codeine administration, and generate evidence to support safer opioid therapy in breastfeeding mothers, breastfed infants, and older children.
Zitieren
APA
Leeder, J. S., Wildt, S. N. D., Gaedigk, A., Reed, M. D., & Knibbe, C. A. (2026). Assessing the Risk of Neonatal Opioid Toxicity from Breastfeeding: Challenge to the Pediatric Clinical Pharmacology Modeling and Simulation Community. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70554
Vancouver
Leeder JS, Wildt SND, Gaedigk A, Reed MD, Knibbe CA. Assessing the Risk of Neonatal Opioid Toxicity from Breastfeeding: Challenge to the Pediatric Clinical Pharmacology Modeling and Simulation Community. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70554
BibTeX
@article{Leeder2026,
author = {Leeder, J. Steven and Wildt, Saskia N. de and Gaedigk, Andrea and Reed, Michael D. and Knibbe, Catherijne A.J.},
title = {Assessing the Risk of Neonatal Opioid Toxicity from Breastfeeding: Challenge to the Pediatric Clinical Pharmacology Modeling and Simulation Community},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
doi = {10.1002/cpt.70554}
}
EUVIMED